Clinical trial / 2018
Daily intake of 2 g of Korean Red Ginseng for 24 weeks was safe and well tolerated in healthy adults.
A total of 1,000 healthy adults were randomized to receive 2 g of Korean Red Ginseng (KRG) daily or a placebo for 24 weeks. Adverse events were reported in 39.2% of the KRG group and 42.0% of the placebo group (p = 0.361), while adverse drug reactions (ADRs) occurred in 12.0% and 11.4%, respectively (p = 0.737). Discontinuation due to ADRs occurred in 1.2% of the KRG group and 1.4% of the placebo group (p = 0.814), with no significant abnormal changes in anthropometric, laboratory, or vital sign measurements between groups.
- Study type
- Multicenter, double-blind, randomized, placebo-controlled trial
- Who was studied
- 1,000 healthy adults
- What was measured
- Adverse events and adverse drug reactions over 24 weeks
THE PAPER
Safety and tolerability of Korean Red Ginseng in healthy adults: a multicenter, double-blind, randomized, placebo-controlled trial.
Song SW, Kim HN, Shim JY, Yoo BY, Kim DH, Lee SH, Park JS, Kim MJ, Yoo JH, Cho B, Kang HC, Kim KM, Kim SS, Kim KS. J Ginseng Res, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.